Elmholdt Tina R, Olesen Anne B B, Jørgensen Bettina, Kvist Stinne, Skov Lone, Thomsen Henrik S, Marckmann Peter, Pedersen Michael
Institute of Clinical Medicine, Aarhus University Hospital, Aarhus University, Aarhus, Denmark ; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
PLoS One. 2013 Dec 9;8(12):e82037. doi: 10.1371/journal.pone.0082037. eCollection 2013.
Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with renal impairment.
The prevalence of nephrogenic systemic fibrosis has so far never been determined at a national level. In 2009, Denmark was the first country to design a guideline for the tracing of nephrogenic systemic fibrosis patients. The aim of this paper is to communicate the main findings of this quest.
The outcome of the nationwide investigation revealed that Denmark had 65 patients with nephrogenic systemic fibrosis and thereby the highest prevalence of nephrogenic systemic fibrosis worldwide with 65 per 5.6 million inhabitants, or 12 per million.
The nationwide investigation in Denmark revealed the highest prevalence of NSF worldwide. This may be rooted in a high level of awareness of NSF both among doctors, politicians and, not least, the media, combined with the fact that a nationwide NSF investigation was initiated.
肾源性系统性纤维化是一种使人衰弱且疼痛的疾病,其会增强皮肤和全身组织中结缔组织的刺激。该疾病与肾功能不全患者在磁共振成像中使用钆基造影剂有关。
迄今为止,肾源性系统性纤维化的患病率从未在国家层面确定过。2009年,丹麦是首个制定肾源性系统性纤维化患者追踪指南的国家。本文旨在传达此次调查的主要结果。
全国性调查结果显示,丹麦有65例肾源性系统性纤维化患者,因此成为全球肾源性系统性纤维化患病率最高的国家,每560万居民中有65例,即每百万中有12例。
丹麦的全国性调查显示该国是全球肾源性系统性纤维化患病率最高的国家。这可能源于医生、政界人士尤其是媒体对肾源性系统性纤维化的高度认知,以及开展了全国性的肾源性系统性纤维化调查。